/* CSS to help with ACF styling */ #page-header .h1 {color: #444;} #page-header h2.text-color-xsdn-color {color: #444;}
/* CSS to help with ACF styling */ #page-header .h1 {color: #fff;} #page-header h2.text-color-xsdn-color {color: #fff;}
/* CSS to help with ACF styling */ #page-header .h1 {color: ;} #page-header h2.text-color-xsdn-color {color: ;}
/* CSS to help with ACF styling */ #page-header {background-color: #031ac3;}
/* CSS to help with ACF styling */ #page-header {background: #fff url() center center; padding-top: 0px; padding-bottom: 0px; } @media all and (max-width: 4699px) and (min-width: 1925px) { .title-and-subtitle-background-image { padding-top: 3% !important; padding-bottom: 3% !important; } }
/* CSS to help with ACF styling */ #page-header {background: ;}

HCCA Compliance TODAY January 2014

A bylined article by FairWarning founder and CEO, Kurt J. Long, in HCCA’s Compliance Today magazine. The article highlights how the final Omnibus Rule removes the ambiguity and uncertainty surrounding healthcare privacy and security compliance requirements enabling care providers to establish and mature sustainable compliance programs.







RELATED LEARNING CENTER

  • Increase Visibility Into Your Drug Diversion Monitoring Program
    Learn More
    Data Sheet
    Increase Visibility Into Your Drug Diversion Program
  • Addressing Drug Diversion in Healthcare - Where do I Start?
    Learn More
    Whitepaper
    Addressing Drug Diversion In Healthcare: Where Do I Start?
  • Learn More
    Data Sheet
    GDPR Mapping Guide